FDA approved the first treatment for metastatic Merkel cell carcinoma (MCC), a rare, aggressive skin cancer. The agency granted accelerated approval to avelumab (Bavencio, EMD Serono) for the trea
Source: First drug for rare skin cancer wins approval | Formulary Journal
A protein can boost blood stem cells, making them behave like those of younger people. Is it the key to harnessing young blood’s rejuvenating power?
Source: Old blood can be made young again and it might fight ageing | New Scientist
Two Advisory Board research leaders discuss the current state of precision medicine – and what it will take for genomics to become part of routine care.
Source: 5 big challenges to utilizing genomic data for precision medicine | Healthcare IT News
A woman in her 80s has become the first person to be successfully treated with induced pluripotent stem (iPS) cells. A slither of laboratory-made retinal cells has protected her eyesight, fighting her age-related macular degeneration – a common form of progressive blindness.
Source: Vision saved by first induced pluripotent stem cell treatment | New Scientist
The first results of gene editing in viable human embryos reveals it works better than we thought, but that there’s another big problem blocking the way
Source: Mosaic problem stands in the way of gene editing embryos | New Scientist
Traders are worried that Repatha isn’t effective enough to justify the drug’s hefty price tag of over $14,500 per year.
Source: Amgen’s cholesterol-fighting drug disappoints, shares drop
Model suggests simple chemical systems could grow and reproduce and could have got life off to a flying start
Source: Riddle of life’s origin may be answered by dividing protocells | Research | Chemistry World